Prognostic impact of adjuvant endocrine therapy for estrogen receptor-positive and HER2-negative T1a/bN0M0 breast cancer

PURPOSE: Mammography screening has increased the detection of subcentimeter breast cancers. The prognosis for estrogen receptor (ER)-positive and human epidermal growth factor receptor 2 (HER2)-negative T1a/bN0M0 breast cancers is excellent; however, the necessity of adjuvant endocrine therapy (ET)...

Descripción completa

Detalles Bibliográficos
Autores principales: Sasada, Shinsuke, Kondo, Naoto, Hashimoto, Hiroya, Takahashi, Yuko, Terata, Kaori, Kida, Kumiko, Sagara, Yasuaki, Ueno, Takayuki, Anan, Keisei, Suto, Akihiko, Kanbayashi, Chizuko, Takahashi, Mina, Nakamura, Rikiya, Ishiba, Toshiyuki, Tsuneizumi, Michiko, Nishimura, Seiichiro, Naito, Yoichi, Hara, Fumikata, Shien, Tadahiko, Iwata, Hiroji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10564809/
https://www.ncbi.nlm.nih.gov/pubmed/37688665
http://dx.doi.org/10.1007/s10549-023-07097-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10564809/
https://www.ncbi.nlm.nih.gov/pubmed/37688665
http://dx.doi.org/10.1007/s10549-023-07097-6

Ejemplares similares